Centocor

From SourceWatch
Jump to: navigation, search

Centocor is a pharmaceutical and biotechnology subsidiary of Johnson & Johnson. It manufactures the biotech drug Remicade, a monoclonal antibody for autoimmune conditions. The company also makes the oncology drugs Doxil and Leustatin as well as the immunosuppressant Orthoclone for organ transplantation. [1] Centocor was founded in 1979 and focused initially on the development of diagnostic assays using monoclonal antibody technology. In subsequent years, the company expanded into drug development. In 1999, Johnson & Johnson acquired Centocor.

J&J established Ortho Biotech in 1990, making it the first biotechnology subsidiary of a major healthcare company. The company focused on cancer, anemia, and rejection of transplanted organs, among other conditions. Centocor Ortho Biotech Inc. was created in 2008 by the merger of Centocor, Inc. and Ortho Biotech Inc. [2]

Centocor Documercial

In February 2007, O'Dwyer's PR Daily reported that J&J's biopharmaceutical unit, Centocor had "developed a documentary film to serve as the centerpiece of a national campaign and an alternative to the 30-second spot." The film, called "Innerstate", follows "three patients living with chronic diseases like Crohn's disease, Rheumatoid arthritis, and psoriasis"; all ailments for which Centocor markets treatments. The company's drugs aren't mentioned in the movie, however. [3]

Animal testing

Centocor does animal testing.

Facility information, progress reports & USDA-APHIS reports

For links to copies of a facility's U.S. Department of Agriculture (USDA)-Animal Plant Health Inspection (APHIS) reports, other information and links, see also Facility Reports and Information: Centocor Research & Development, Malvern, PA. [4]

USDA AWA reports

As of May 26, 2009, the USDA began posting all inspection reports for animal breeders, dealers, exhibitors, handlers, research facilities and animal carriers by state. See also USDA Animal Welfare Inspection Reports.

Key executives

  • Kim Taylor - President
  • Jay Siegel - Chief Biotechnology Officer
  • Jerome Boscia - Sr. VP - Clinical Research & Development [5]

Contact

800 Ridgeview Rd.
Horsham, PA 19044
United States

Phone: 610-651-6000

Fax: 610-651-6100

Toll Free: 800-457-6399

Web address: http://www.centocor.com/

Articles & sources

Sourcewatch articles

References

  1. Company Description: Centocor, Hoovers, accessed March 2010
  2. Company History, Centocor, accessed March 2010
  3. Centocor Innerstate, O'Dwyer's PR Daily, February 2007
  4. Facility Reports and Information: Centocor Research & Development, Malvern, PA, Stop Animal Experimentation NOW!, accessed January 2011
  5. Company Description: Centocor, Hoovers, accessed March 2010

External articles